BlackRock Capital Allocation Term Trust of (BCAT) Options Positioning, Max Pain & Unusual Sweeps

$13.81 +1.84% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)

BlackRock Capital Allocation Term Trust of (BCAT) carries a Roarable Rating of D+ (Sell) with 53/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D+ • SELL / AVOID Cap $1.49B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
RQD QUANT TACHOMETERSELL / AVOID • D+
025507510053
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk D+
Cash (11)Whales (10)SEC (13)Macro (10)CEO (9)
Each axis scored 0–20
12M PRICE TARGET CONE-2.2% Base Target
$17 Bull$14 Base$11 Bear
📬 FREE BCAT RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BCAT)Realized 20D OHLCV Swing Band: ±3.4%
CALL VS. PUT WHALE SHARE
— (No Active Options Snapshot)
Put/Call Ratio: — (No Active Options Snapshot)
MAX-PAIN EXPIRATION MAGNET
— (No Active Options Snapshot)
No active options chain max-pain snapshot on file
HISTORICAL 20D VOLATILITY SWING
±3.4%
Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (BCAT)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for BCAT.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BCAT)

  • ✓Walkthrough of BCAT's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
BCAT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -8.54%📐 HORIZONTAL RANGE
2026-10-30O $13.70H $13.93L $13.65C $13.81VOL 709.0K
RES: $16.24SUP: $12.63SMA50: $14.34SMA200: $15.03
$16.43$15.48$14.52$13.57$12.61RES $16.24SUP $12.63$13.812026-04-302026-06-152026-07-312026-09-162026-10-30
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BCAT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BCAT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BCAT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for BCAT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BCAT)

Financials Rank #735 of 1096 ⚔️ ECAT vs BCAT Full Matrix →

1. Head-to-Head Financials Peer Comparison (BCAT vs. ECAT, KYN, BTZ, BCX)

Industry: Finance/Investors Services (37 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, BlackRock Capital Allocation Term Trust of (BCAT) ranks #735 by composite RQD confidence (53/100, grade D+) and #490 by equity capitalization ($1.49B). Within this direct 5-issuer industry benchmark cohort, BCAT leads on earnings valuation at N/A trailing P/E, while BCAT leads on capital efficiency and profitability with — ROIC and — gross margin. KYN currently holds the highest overall quantitative score in the immediate peer group at 60/100 (C-) compared with BCAT at 53/100 (D+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
BCAT ACTIVE
BlackRock Capital Allocation Term Trust of
D+ 53/100 — — — +1.84% $1.49B Benchmark Subject
ECAT
BlackRock ESG Capital Allocation Term Trust of
D 51/100 — — — +1.41% $1.47B /ecat-vs-bcat →
KYN
Kayne Anderson Energy Infrastructure Fund Inc.
C- 60/100 — — — +2.30% $2.00B /kyn-vs-bcat →
BTZ
BlackRock Credit Allocation Income Trust
D+ 54/100 — — — +1.16% $1.04B /btz-vs-bcat →
BCX
BlackRock Resources of
D+ 57/100 — — — +0.67% $1.02B /bcx-vs-bcat →

2. BCAT Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

BlackRock Capital Allocation Term Trust of (BCAT) operates in Finance/Investors Services (Financials) with an equity capitalization of $1.49B, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. BCAT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BCAT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, BlackRock Capital Allocation Term Trust of (NYSE: BCAT) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 53/100 at a spot price of $13.81 (+1.84% 1D, market cap $1.49B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1096 tracked Financials issuers, BCAT ranks #735 in composite RQD confidence.

How does BCAT compare to ECAT and KYN in the Financials sector?

Within the Financials sector (Finance/Investors Services), BCAT carries a Roarable D+ (53/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, ECAT (BlackRock ESG Capital Allocation Term Trust of) holds a D grade (51/100 RQD, P/E N/A, ROIC —, cap $1.47B) and KYN (Kayne Anderson Energy Infrastructure Fund Inc.) posts a C- grade (60/100 RQD, P/E N/A, ROIC —, cap $2.00B). Among the 5-stock peer group, BCAT leads on earnings multiple (N/A) while BCAT leads on capital efficiency (— ROIC).

What are the biggest fundamental strengths and SEC risk factors for BCAT?

For BlackRock Capital Allocation Term Trust of (BCAT), key quantitative strengths include Established market leader in Financials with deep daily trading liquidity. and sector rank #735 in Financials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is BCAT trading relative to its 50-day, 200-day, and 52-week technical levels?

BCAT last traded at $13.81 (+1.84% on volume of 507,434 shares), positioning the stock -3.70% below its 50-day simple moving average ($14.34) and -8.12% below its 200-day simple moving average ($15.03). Across its 52-week range of $12.92 to $16.20, BCAT sits at the 27.1% percentile with a 14-day RSI of 52.4 (NEUTRAL RANGE) and an implied next-earnings move of ±3.4% ($13.34 to $14.28).

BCAT Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is BCAT's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for BCAT.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $213.66 -0.80% AAPL $348.91 +1.48% MSFT $530.14 -0.16% TSLA $403.30 -0.23% PLTR $196.42 -0.20% SOFI $17.61 +2.74% IBIT $43.36 -0.94% GLD $355.78 -1.34%